UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 29, 2018
Accession Number:
Submission Type:
CIK:
0001600620
Company Name:
Aurinia Pharmaceuticals Inc.
File Number:
333-222413